Form D · Other Health Care
Arthritis Innovation Corp
Toronto, A6 · CIK 0001697507
Offering snapshot reported Feb 9, 2017 · SEC filing
- Reported sold
- $324K Offering amount: $324K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jan 26, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 9, 2017 | Initial | $324,350 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280422
Source: Form D, filed Feb 9, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Glenys Foster Roberts | Director, Executive |
| Mark Krembil | Director |
| Brian Levitt | Director |
| Nizar Mahomed | Director, Executive |
| Dr. Wayne Marshall | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5 Fallingbrook Crescent
Toronto, A6, M1N1B1
Toronto, A6, M1N1B1